Germany - Healthcare, Regulatory and Reimbursement Landscape

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $1,995	172 Pages	GlobalData	June, 2021	GBDT16681279

Best Price Guarantee
Price	from $1,995
Length	172 Pages
Publisher	GlobalData
Published Date	June, 2021
SKU	GBDT16681279

Germany - Healthcare, Regulatory and Reimbursement Landscape

Summary

GlobalData, the industry analysis specialist, has released its latest report, Germany - Healthcare, Regulatory and Reimbursement Landscape. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Germany. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

The German pharmaceutical market is the largest by value and second largest by volume in Europe. Globally, it is the fourth largest market by value after the US, China, and Japan. The market value, in terms of Euros, increased from €42.1B in 2013 to an estimated €62.4B in 2020 at a Compound Annual Growth Rate (CAGR) of 5.8%. In terms of US dollars, the market increased from $56B in 2013 to an estimated $71.3B in 2020 at a CAGR of 3.7%. The medical devices market of Germany was $21.6B in 2017, which increased at a CAGR of 3% to reach $23.5B in 2020. The market is expected to grow at a CAGR of 4.7% from $26.6B in 2021 to reach $29.6B in 2025.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Germany, and includes -

An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers
Profiles and SWOT analyses of the major players in the pharmaceutical market: Bayer, Boehringer Ingelheim, GlaxoSmithKline, Merck KGaA, and Pfizer.
Profiles and SWOT analyses of the major players in the medical device market: Abbott, Alcon, GE Healthcare, Fresenius, and Roche Diagnostics
An insightful review of the COVID-19 epidemiology, COVID-19 impact, and developments in healthcare market, HealthTech landscape, reimbursement, and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices
Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure
An overview of the opportunities for and challenges to growth in the German healthcare market

Reasons to Buy

This report will enhance your decision-making capability by allowing you to -

Develop business strategies by understanding the trends shaping and driving the German healthcare market
Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact the German healthcare market in the future
Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

1. Table of Contents: 1.1 List of Figures; 1.2 List of Tables
2. Executive Summary: 2.1 Executive Summary; 2.2 Key Highlights - Facts about the German Healthcare Market; 2.3 Key Highlights: Healthcare Startups in Germany; 2.4 Key Events: German Healthcare Industry, 2015-2021; 2.5 Key Events: German Pharmaceutical Market; 2.6 Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2019-2020; 2.7 Key Events: Mergers and Acquisitions; 2.8 Country Profile, Germany, 2020
3. Overview of Pharmaceutical Market: 3.1 Pharmaceutical Market - Overview; 3.2 Impact of Brexit on the German Health Sector; 3.3 Pharmaceutical Market - Exports; 3.4 Pharmaceutical Market - Imports; 3.5 Pharmaceutical Market - Supply Channels, Germany; 3.6 Pharmaceutical Market - Market Segments; 3.7 Major Therapeutic Areas, Germany; 3.8 COVID-19 Epidemiology, Germany; 3.9 COVID-19 Impact and Developments, Germany; 3.10 COVID-19 Impact and Developments in the Healthcare Market, Germany; 3.11 COVID-19 Clinical Trials Landscape, Germany; 3.12 Pharmaceutical Market - Major Players
4. Overview of Medical Devices Market: 4.1 Medical Device Market - Overview; 4.2 Medical Devices Market - Major Players
5. Pharmaceutical and Medical Devices Market - Drivers and Barriers: 5.1 Drivers; 5.2 Barriers
6. Deal Analysis: 6.1 Deal Analysis: Pharmaceutical Market, Germany, 2020-2021; 6.2 Deal Analysis: Medical Device Market, Germany, 2020-2021
7. HealthTech Landscape: 7.1 HealthTech Landscape, Germany; 7.2 HealthTech Deals Landscape, Germany; 7.3 Key HealthTech Deals, Germany; 7.4 Adoption of Technology in Healthcare, Germany; 7.5 Digital Health Regulations, Germany; 7.6 Digital Health: Benefits and Risks, Germany
8. Market Access: 8.1 Overview of Healthcare System, Germany; 8.2 Reimbursement Process, Germany; 8.3 Overview of Insurance Providers, Germany; 8.4 Out-of-Pocket Spending and Pharmaceutical Price Index, Germany; 8.5 Pricing Policies, Germany; 8.6 Regulatory Landscape, Germany; 8.6.1 Overview of Regulatory Agencies, Germany; 8.6.2 Marketing Authorization for Pharmaceutical Products, EU; 8.6.3 Marketing Authorization for Pharmaceutical Products, Centralized Procedure, Germany; 8.6.4 Marketing Authorization for Pharmaceutical Products, Mutual Recognition Procedure, Germany; 8.6.5 Marketing Authorization for Pharmaceutical Products, Decentralized Procedure, Germany; 8.6.6 Marketing Authorization for Pharmaceutical Products, National Procedure, Germany; 8.6.7 Marketing Authorization for Generic Drugs, Germany; 8.6.8 Marketing Authorization for Biosimilars, Germany; 8.6.9 Marketing Authorization for Medical Devices, Germany; 8.6.10 Exports and Imports, Germany; 8.6.11 Intellectual Property Rights, Patent, Germany; 8.6.12 Intellectual Property Rights, Trademark, Germany; 8.6.13 Clinical Trial Regulations, Germany; 8.6.14 Pharmaceutical Clinical Trials Landscape, Germany; 8.6.15 Medical Devices Clinical Trials Landscape, Germany; 8.6.16 Pharmacy License Regulations, Germany; 8.6.17 Online Pharmacy Regulations, Germany; 8.6.18 Pharmaceutical Advertising Regulations, Germany; 8.6.19 Labeling and Packaging Regulations, Germany
9. Country Healthcare Landscape: 9.1 Healthcare Policy Highlights, Germany; 9.2 Healthcare Facilities, Germany; 9.3 Healthcare Parameters, Germany; 9.4 Life Expectancy and Immunization Rate, Germany; 9.5 Environmental Health, Germany; 9.6 Healthcare Personnel, Germany; 9.7 Disease Burden, Germany; 9.8 Healthcare Expenditure, Germany; 9.9 Healthcare Spending Components and Pharmaceutical Spending, Germany
10 Trade Associations, Germany
11 Trade Fairs, Germany
12 Opportunities and Challenges
13 Appendix: 13.1 Research Methodology; 13.1.1 Coverage; 13.1.2 Secondary Research; 13.1.3 Forecasts; 13.2 Bibliography; 13.3 About GlobalData; 13.4 Contact Us; 13.5 Disclaimer
List of Tables: Table 1: Biotechnology Companies General Data, Germany, 2018-2019; Table 2: Biosimilars approved in 2021, Germany, 2021; Table 3: COVID-19 Indicators (Number of cases), Germany and Global, 2020-2021; Table 4: COVID-19 Vaccines, Germany, 2020-2021; Table 5: Medical Devices Market, Germany, Major Segments ($B), 2020; Table 6: General Surgery Devices Market, Germany, Revenue ($M) and Market Share (%) of Major Companies, 2020; Table 7: Cardiovascular Devices Market, Germany, Revenue ($M) and Market Share (%) of Major Companies, 2020; Table 8: Healthcare IT Market, Germany, Revenue ($M) and Market Share (%) of Major Companies, 2018; Table 9: Orthopedic Devices Market, Germany, Revenue ($M) and Market Share (%) of Major Companies, 2020; Table 10: In Vitro Diagnostics Market, Germany, Revenue ($M) and Market Share (%) of Major Companies, 2020; Table 11: New Drug Application Information, Germany, 2021; Table 12: Patent Fees, Germany, 2020; Table 13: Trademark Fees, Germany, 2020; Table 14: Clinical Trial Fees, Germany, 2020; Table 15: Label of a Pharmaceutical Product, Germany, 2020; Table 16: Label of Radiopharmaceutical Product, Germany, 2020; Table 17: Labeling of Small Packages, Germany, 2020; Table 18: Labeling and Packaging Leaflet, Germany, 2020; Table 19: Conferences and Trade Fairs, Germany, 2021
List of Figures: Figure 1: Pharmaceutical Market, Germany, Revenue ($B and €B), 2013-2020; Figure 2: Medical Devices Market, Germany, Revenue ($B), 2017-2022; Figure 3: Healthcare Startups in Germany, 2020; Figure 4: Country Profile, Germany, 2020; Figure 5: Pharmaceutical Market, Germany, Revenue ($B), 2012-2019; Figure 6: Pharmaceutical Market, Germany, Revenue Forecast ($B), 2020-2025; Figure 7: Pharmaceutical Exports ($B), Germany, 2012-2020; Figure 8: Top Export Partners, Germany, 2020; Figure 9: Pharmaceutical Imports ($B), Germany, 2012-2020; Figure 10: Top Import Partners, Germany, 2020; Figure 11: Generic Drugs (Market share % by value and volume), Germany, 2010-2018; Figure 12: Generic Drug Marketing Authorization Applications (Number), EU, 2015-2021; Figure 13: Biotechnology SME Share (%), Germany, 2020; Figure 14: OTC Medicines Market, Revenue ($B), Germany, 2013-2020; Figure 15: OTC Medicines Market, Major Categories ($M), Germany, 2020; Figure 16: OTC Medicines Market, Major Distribution Channels ($M), Germany, 2017; Figure 17: Pharmaceutical Sales by Drug Category ($B), Germany, 2019; Figure 18: Major Therapeutic Areas by Pharmaceutical Consumption (DDD per million inhabitants), Germany, 2016-2018; Figure 19: COVID-19 (Number of cases), Germany, 2020-2021; Figure 20: COVID-19 (Number of deaths), Germany, 2020-2021; Figure 21: COVID-19 Risk Areas Classification, Germany, 2020-2021; Figure 22: COVID-19 Fiscal Stimulus Timeline, Germany, 2020-2021; Figure 23: COVID-19 Vaccination Priority Groups, Germany, 2020-2021; Figure 24: COVID-19 Vaccine Administration, Number of People, Germany, 2020-2021; Figure 25: Top COVID-19 Marketed Products by Category (Number of available marketed products), Germany, 2020-2021; Figure 26: Top COVID-19 IVD Products by Equipment Type (Number of available marketed products), Germany, 2020-2021; Figure 27: Top COVID-19 Marketed Products by Product Class (Number of available marketed products), Germany, 2020-2021; Figure 28: Top COVID-19 Anesthesia and Respiratory Devices Products by Equipment Type (Number of available marketed products), Germany, 2020-2021; Figure 29: COVID-19 Clinical Trials Count by Phase, Germany, 2020-2021; Figure 30: COVID-19 Clinical Trials Count by Trial Status, Germany, 2020-2021; Figure 31: Top Five COVID-19 Clinical Trials Sponsors by Count, Germany, 2020-2021; Figure 32: Pharmaceutical Market, Major Players, 2020; Figure 33: Medical Devices Market, Germany, Revenue ($B), 2015-2020; Figure 34: Medical Devices Market, Germany, Revenue Forecast ($B), 2021-2025; Figure 35: Medical Devices Market, Germany, Major Segments (%), 2020; Figure 36: General Surgery Devices Market, Germany, Revenue ($B), 2017-2025; Figure 37: General Surgery Devices Market, Germany, Market Share of Major Players (%), 2020; Figure 38: Cardiovascular Devices Market, Germany, Revenue ($B), 2017-2025; Figure 39: Cardiovascular Devices Market, Germany, Market Share of Major Players (%), 2020; Figure 40: Healthcare IT Market, Germany, Revenue ($B), 2017-2025; Figure 41: Healthcare IT Market, Germany, Market Share of Major Players (%), 2018; Figure 42: Orthopedic Devices Market, Germany, Revenue ($B), 2017-2025; Figure 43: Orthopedic Devices Market, Germany, Market Share of Major Players (%), 2020; Figure 44: In Vitro Diagnostics Market, Germany, Revenue ($B), 2017-2025; Figure 45: In Vitro Diagnostics Market, Germany, Market Share of Major Players (%), 2020; Figure 46: Diagnostic Market, Germany, Revenue ($B), 2015-2020; Figure 47: Diagnostic Market, Germany, Revenue ($B), 2021-2025; Figure 48: Medical Devices Market, Germany, Revenue ($B) of Major Companies, 2020; Figure 49: Deal Value and Deal Count, Pharmaceutical Market, Germany, 2020-2021; Figure 50: Deal Value and Deal Count, Quarterly, Pharmaceutical Market, Germany, 2020-2021; Figure 51: Deal Value and Deal Count Sub-types, Pharmaceutical Market, Germany, 2020-2021; Figure 52: Top Therapy Areas by Deal Value, Pharmaceutical Market, Germany, 2020-2021; Figure 53: Top Therapy Areas by Deal Count, Pharmaceutical Market, Germany, 2020-2021; Figure 54: M&A Deals by Quarter, Pharmaceutical Market, Germany, 2020-2021 (by value and by number); Figure 55: VC Deals by Quarter, Pharmaceutical Market, Germany, 2020-2021 (by value and by number); Figure 56: Deal Value and Deal Count, Medical Devices Market, Germany, 2020-2021; Figure 57: Deal Value and Deal Count, Quarterly, Medical Devices Market, Germany, 2020-2021